Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease-Reference-Cited by-同舟云学术

Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease

Published:2019-02 Issue:2 Volume:25 Page:265-269
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Modi Badri,Hernandez-Henderson Michael,Yang Dongyun,Klein Jeremy,Dadwal Sanjeet,Kopp Erin,Huelsman Karen,Mokhtari Sally,Ali Haris,Malki Monzr M. Al,Spielberger Ricardo,Salhotra Amandeep^ORCID,Zain Jasmine,Cotliar Jonathan,Parker Pablo,Forman Stephen,Nakamura Ryotaro

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference18 articles.

1. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease;Inamoto;Blood,2013

2. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD;Wolff;Biol Blood Marrow Transplant,2010

3. Consensus Conference on Clinical Practice in Chronic GVHD: second-line treatment of chronic graft-versus-host disease;Wolff;Biol Blood Marrow Transplant,2011

4. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report;Jagasia;Biol Blood Marrow Transplant,2015

5. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report;Lee;Biol Blood Marrow Transplant,2015

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis;Annals of Hematology;2024-06-25

2. TET2–STAT3–CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition;Journal of Experimental Medicine;2024-05-28

3. Efficacy and safety in early application of Ruxolitinib for high-risk acute lymphoblastic leukemia to prevent GVHD and recurrence after allogeneic hematopoietic stem cell transplantation;Transplant Immunology;2024-04

4. PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation;Blood Cancer Journal;2024-03-15

5. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults;European Respiratory Journal;2024-03